Ophthalmology Advisor

🦃 📢 November's FDA Roundup is here... Catch up on latest announcements and approvals from the U.S. Food and Drug Administration (FDA) concerning #Ophthalmology. 👁️ LumiThera Inc: Valeda Light Delivery System - LumiThera, Inc., David Boyer, MD, Retina-Vitreous Associates Medical Group 👁️ Epioxa: Keratoconus - Glaukos Corporation 👁️ FLQ-101: Retinopathy of Prematurity - FELIQS® 👁️ Nipocalimab: Sjögren Disease - Terence Rooney VP, Johnson & Johnson Innovative Medicine Read the full article here ➡️: https://bit.ly/3MeeGJn -------------------------------- #FDARoundup #ValedaLightDeliverySystem #LumiTheraInc #DryAMD #AgeRelatedMacularDegeneration #ValedaTheraoy #USLIGHTSITEIII #NCT04065490 #ClinicalTrials #Epioxa #Keratoconus #Glaukos #CXLTherapy #CornealCrossLinkingTherapy #CXL #FLQ101 #RetinopathyOfPrematurity #ROP #FastTrack #OrphanDrug #tROPhy1 #FELIQS #Nipocalimab #SjögrenDisease #JohnsonAndJohnson #BTD #BreakthroughTherapyDesignation #SjD #FcRnBlocker #PatientOutcomes #EyeHealth #EyeCare #Ophthalmology #Ophthalmologist #EyeDoctor #EyeCareProfessionals #HCSM #Pharma #EyeResearch    

Cataract surgeons Vance Thompson, MD, Cathleen McCabe, MD, and Ravi D. Goel, MD, MD, prioritize patient education around the intraocular lens selection process. Cataract surgeons are responsible for advising patients on a decision that will have lifelong implications. Identifying the intraocular lens (IOL) choice most suited for a particular patient’s lifestyle should be done with the patient’s careful consideration, and full understanding of the portfolio of options before them. However, with so many recent technological advances, that portfolio has expanded, and the intraocular lens choices are more diverse than ever. What was once a limited menu has expanded into a kaleidoscopic array of options, especially for patients who are willing to pay out of pocket. Read here: https://bit.ly/4gOCim5 #IntraocularLens #IOL #Cataract #Cataracts #CataractSurgeon #EyeCare #PatientEducation #Ophthalmology #EyeHealth #Ophthalmologist

Color is a key component of any professional branding or design endeavor, and the use of color in health care settings is no exception. Although color psychology has the potential to affect patient experiences and outcomes, it remains relatively underexplored relative to its extensive use in marketing.1 As research consistently demonstrates the profound impact of color on consumer behavior, there is a compelling case for applying these insights to patient floors, waiting rooms, and physician branding. Read here: https://bit.ly/4ePcioa #Color #Healthcare #ColorPsychology #EyeHealth #ConsumerBehavior

Topline results were announced from a phase 3 trial evaluating an oral, fixed-dose combination of midazolam and ketamine for procedural sedation during cataract surgery. Read more: https://bit.ly/40ZnoEa #Phase3Trial #ClinicalTrial #Midazolam #Ketamine #ProceduralSedation #Cataracts #CataractSurgery #EyeSurgery #EyeSurgeon #Ophthalmology #EyeCare #EyeHealth

Time to bookmark a cheat sheet 📑⭐ Take a look at this comprehensive table of Ophthalmology ICD 10 codes used by researchers and healthcare professionals and personnel – nurses, medical coders, physicians, et al. This table has been curated for Ophthalmology specialists to include all Ophthalmology ICD 10 codes and classifications covering common ophthalmologic conditions. Read here➡️ : https://bit.ly/3B2o1Ca #ICD10Codes #ICD10 #Healthcare #Ophthalmology #Ophthalmologist #EyeResearch #HealthcareProfessionals #Nurses #MedicalCoders #Physicians #Ophthalmologists #EyeCare #EyeHealth #OphthalmologyOffice #MedicalOffice

Patients with migraine are more likely to experience open-angle glaucoma (OAG), according to research published in Journal of Glaucoma. Read more: https://bit.ly/4eABwqs #Migraine #OpenAngleGlaucoma #OAG #Ophthalmology #EyeCare #EyeHealth

For patients with axial spondyloarthritis (axSpA) who experience extra musculoskeletal symptoms such as acute anterior uveitis, bimekizumab (BKZ) may offer protective benefits, according to study results published in Annals of the Rheumatic Diseases. Read more: https://bit.ly/495FhTH #AxialSpondyloarthritis #axSpA #MusculoskeletalSymptoms #AcuteAnteriorUveitis #Bimekizumab #BKZ #RheumaticDiseases #Rheumatology #Ophthalmology #EyeCare

President-elect Donald Trump has announced his picks for key health positions in his new cabinet. To run the U.S. Centers for Disease Control and Prevention, Trump has turned to David Weldon, M.D., a long-time internist who interrupted his medical career to represent a Florida district for seven terms in the U.S. House of Representatives before returning to medical practice. According to The New York Times, some of Weldon’s opinions have been controversial, including endorsing the notion that thimerosal, a preservative used in some vaccines, is a cause of autism in children. That theory has long been discredited by science. In 2007, Weldon also sponsored a failed bill in Congress, which called for vaccine safety research to be conducted by a separate agency within the U.S. Department of Health and Human Services. Trump has turned to The Johns Hopkins University School of Medicine pancreatic surgeon Martin Makary, M.D., to run the U.S. Food and Drug Administration (FDA). According to The Times, Makary is, on the whole, supportive of childhood vaccines, although he has voiced concern about certain shots, such as the hepatitis B vaccine for newborns and the need for a third COVID-19 booster for healthy children. He has also been a vocal critic of vaccine mandates, claiming instead that doctors underestimate the power of natural immunity in warding off disease. Trump’s pick to be the new surgeon general is Janette Nesheiwat, M.D. She is medical director of CITYMD, a chain of urgent care centers, and a frequent Fox News contributor, according to The Times. She is on record as being generally supportive of COVID-19 vaccines, once telling Fox News that they were a “gift from God.” But she has also voiced opposition to vaccine mandates. Read more: https://bit.ly/4i84EbC #HCSM #MedLI #HealthCare #HealthCareNews #HealthCareProfessionals #MedicalNews #CDC #FDA #SurgeonGeneral

Fluorescein angiography is a valuable diagnostic tool, but it’s not without its limitations. It’s invasive, for some patients it can cause a severe allergic reaction, and a recent shortage of fluorescein may make it necessary to limit the use of this imaging technology and potentially seek a surrogate marker of inflammation. Artificial intelligence (AI) just may help clinicians accomplish that, according to S. Saeed Mohammadi, MD, FICO, who presented a paper on the topic at the American Academy of Ophthalmology (AAO) 2024 meeting, held in Chicago from October 18 to October 21, 2024. #AAO2024 Read more: https://bit.ly/3AZfDmU #FluoresceinAngiography #AllergicReaction #Inflammation #Uveitis #AI #MedTech #FundusPhotography #NoninfectiousUveitis #Ophthalmology #EyeCare

A polygenic risk scoring system can help predict glaucomatous risk factors, including intraocular pressure (IOP) elevation and changes to the optic nerve vertical cup-to-disc ratio (VCDR), according to a study published in JAMA Ophthalmology. The report, authored by the Australian research team who constructed the polygenic risk scoring system, suggests that use of these scores may sooner identify patients most likely to benefit from more intensive IOP-lowering treatments. Read here: https://bit.ly/492RGaV #PolygenicRiskScoringSystem #Glaucoma #GlaucomatousRiskFactors #IOP #EyeCare #IntraocularPressure #VCDR #Ophthalmology #EyeHealth